48
Participants
Start Date
August 31, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
PURETHAL Mites 20,000 AUeq/ml
"Group 1: slow regimen (12+2 injections) Initial treatment: incremental weekly dose of 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 1.0, 1.2\*, 1.6\* and 2.0\* ml Additional maintenance: 2 two-weekly injections 2.0\* ml~\*Injection volumes larger than 1 ml will be given as 2 separate injections of equal volume within an area of 1 cm."
PURETHAL Mites 20,000 AUeq/ml
"Group 2: intermediate regimen (9+2 injections) Initial treatment: incremental weekly dose of 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2\*, 1.6\* and 2.0\* ml.~Additional maintenance: 2 two-weekly injections 2.0\* ml~\*Injection volumes larger than 1 ml will be given as 2 separate injections of equal volume within an area of 1 cm."
PURETHAL Mites 20,000 AUeq/ml
"Group 3: fast initial treatment (6+2 injections) Initial treatment: incremental weekly dose of 0.2, 0.4, 0.8, 1.2\*, 1.6\* and 2.0\*ml.~Additional maintenance: 2 two-weekly injections 2.0\* ml~\*Injection volumes larger than 1 ml will be given as 2 separate injections of equal volume within an area of 1 cm."
Allergie-Centrum Charité, Klinik für Dermatologie, Venerologie und Allergologie, Charité Campus Mitte, Universitätsmedizin Berlin, Berlin
Hals, Nasen- und Ohrenheilkunde, Berlin
Allergy & Asthma Center Westend, Berlin
Universitätsklinikum Düsseldorf, Düsseldorf
Allergologie HNO-Heilkunde, Schorndorf
Klinik für Dermatologie und Allergie, Krankenhaus Bad Cannstatt, Stuttgart
Lead Sponsor
HAL Allergy
INDUSTRY